Voisset Edwige, Lopez Sophie, Dubreuil Patrice, De Sepulveda Paulo
Institut National de la Santé et de la Rècherche Médicale (INSERM), Unité Mixte de Recherche (UMR) 599, Centre de Recherche en Cancérologie de Marseille, Laboratoire d'Hématopoïèse Moléculaire et Fonctionnelle, Marseille, France.
Blood. 2007 Oct 1;110(7):2593-9. doi: 10.1182/blood-2007-02-076471. Epub 2007 Jun 26.
KIT is a tyrosine kinase receptor that is aberrantly activated in several neoplasms. In human pathologies, the most frequent mutation of KIT occurs at codon 816. The resulting KIT mutant protein is activated in the absence of ligand and is resistant to the clinically available inhibitors of KIT. In this report, we provide evidence for an essential function of the cytoplasmic tyrosine kinase FES downstream of KIT(D816V). FES is phosphorylated on tyrosine residues in cells that carry KIT(D816V) mutation, and this phosphorylation is KIT dependent. Reduction of FES expression using RNA interference results in decreased cell proliferation in human or murine cells harboring KIT(D816V) or the homologous mouse mutation KIT(D814Y). The reduced cell growth can be rescued using another cytokine (granulocyte-macrophage colony-stimulating factor [GM-CSF]) and is not observed when the closely related fer gene is targeted. Finally, signaling downstream of KIT(D816V) is altered in cells lacking FES expression. This study shows a major function of FES downstream of activated KIT receptor and thereby points to FES as a novel target in KIT-related pathologies.
KIT是一种酪氨酸激酶受体,在多种肿瘤中被异常激活。在人类病理学中,KIT最常见的突变发生在第816密码子。产生的KIT突变蛋白在没有配体的情况下被激活,并且对临床上可用的KIT抑制剂具有抗性。在本报告中,我们提供了证据证明细胞质酪氨酸激酶FES在KIT(D816V)下游具有重要功能。在携带KIT(D816V)突变的细胞中,FES在酪氨酸残基上被磷酸化,并且这种磷酸化是KIT依赖性的。使用RNA干扰降低FES表达会导致携带KIT(D816V)或同源小鼠突变KIT(D814Y)的人或小鼠细胞中的细胞增殖减少。使用另一种细胞因子(粒细胞-巨噬细胞集落刺激因子[GM-CSF])可以挽救细胞生长的降低,而当靶向密切相关的fer基因时则未观察到这种情况。最后,在缺乏FES表达的细胞中,KIT(D816V)下游的信号传导发生改变。这项研究显示了激活的KIT受体下游FES的主要功能,从而指出FES是KIT相关病理学中的一个新靶点。